Bertin E - Search Results

1

Production of Elastin-Derived Peptides Contributes to the Development of Nonalcoholic Steatohepatitis.

Romier B, Ivaldi C, Sartelet H, Heinz A, Schmelzer CEH, Garnotel R, Guillot A, Jonquet J, Bertin E, Guéant JL, Alberto JM, Bronowicki JP, Amoyel J, Hocine T, Duca L, Maurice P, Bennasroune A, Martiny L, Debelle L, Durlach V, Blaise S. Romier B, et al. Among authors: bertin e. Diabetes. 2018 Aug;67(8):1604-1615. doi: 10.2337/db17-0490. Epub 2018 May 25. Diabetes. 2018. PMID: 29802129

2

Serum lipoprotein (a) concentrations in a population of 819 non-insulin-dependent diabetic patients.

Durlach V, Gillery P, Bertin E, Taupin JM, Grulet H, Gross A, Leutenegger M. Durlach V, et al. Among authors: bertin e. Diabetes Metab. 1996 Oct;22(5):319-23. Diabetes Metab. 1996. PMID: 8896993

3

Evaluation of serum glycated lipoprotein(a) levels in noninsulin-dependent diabetic patients.

Klaya F, Durlach V, Bertin E, Monier F, Monboisse JC, Gillery P. Klaya F, et al. Among authors: bertin e. Clin Biochem. 1997 Apr;30(3):227-30. doi: 10.1016/s0009-9120(97)00026-x. Clin Biochem. 1997. PMID: 9167899

4

Influence of endogenous and environmental factors on variations of serum lipoprotein (a) concentrations in a large population of insulin-treated diabetic patients.

Durlach V, Gillery P, Bertin E, Grulet H, Gross A, Leutenegger M. Durlach V, et al. Among authors: bertin e. Diabetes Metab. 1998 Apr;24(2):124-30. Diabetes Metab. 1998. PMID: 9592636

5

Insulin and body fat distribution have no direct effect on plasma leptin levels in obese Caucasian women with and without type 2 diabetes mellitus.

Bertin E, Rich N, Schneider N, Larbre H, Marcus C, Durlach V, Leutenegger M. Bertin E, et al. Diabetes Metab. 1998 Jun;24(3):229-34. Diabetes Metab. 1998. PMID: 9690055 Clinical Trial.

6

Plasma levels of tumor necrosis factor-alpha (TNF-alpha) are essentially dependent on visceral fat amount in type 2 diabetic patients.

Bertin E, Nguyen P, Guenounou M, Durlach V, Potron G, Leutenegger M. Bertin E, et al. Diabetes Metab. 2000 May;26(3):178-82. Diabetes Metab. 2000. PMID: 10880890

7

Therapeutic problems in type II diabetic patients developing insulin requirement.

Leutenegger M, Bertin E, Grulet H. Leutenegger M, et al. Among authors: bertin e. J Diabetes Complications. 1996 Sep-Oct;10(5):255-60. doi: 10.1016/1056-8727(96)00043-8. J Diabetes Complications. 1996. PMID: 8887013 Review. No abstract available.

8

No major role for the CTLA-4 gene in the association of autoimmune thyroid disease with IDDM.

Djilali-Saiah I, Larger E, Harfouch-Hammoud E, Timsit J, Clerc J, Bertin E, Assan R, Boitard C, Bach JF, Caillat-Zucman S. Djilali-Saiah I, et al. Among authors: bertin e. Diabetes. 1998 Jan;47(1):125-7. doi: 10.2337/diab.47.1.125. Diabetes. 1998. PMID: 9421385 No abstract available.

9

[Escaping oral hypoglycemic agents in type 2 diabetes: importance and limitations of transitory optimized insulin therapy].

Leutenegger M, Bertin E, Grulet H. Leutenegger M, et al. Among authors: bertin e. Diabetes Metab. 1998 Feb;24(1):80-4. Diabetes Metab. 1998. PMID: 9534015 Review. French. No abstract available.

10

Gastric emptying is accelerated in obese type 2 diabetic patients without autonomic neuropathy.

Bertin E, Schneider N, Abdelli N, Wampach H, Cadiot G, Loboguerrero A, Leutenegger M, Liehn JC, Thiefin G. Bertin E, et al. Diabetes Metab. 2001 Jun;27(3):357-64. Diabetes Metab. 2001. PMID: 11431601

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

185 results

Search Page

Filters